Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T3RR
|
|||
| Former ID |
DIB009526
|
|||
| Drug Name |
ISIS-ANGPTL3
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Hyperlipidaemia [ICD-11: 5C80; ICD-10: E78.5] | Phase 1 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ANGPTL3 messenger RNA (ANGPTL3 mRNA) | Target Info | . | [2] |
| Pathway Interaction Database | Integrins in angiogenesis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals. | |||
| REF 2 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.